NCT00279565View on ClinicalTrials.gov

Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)

PHASE4TerminatedINTERVENTIONAL

Enrollment

128

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Hepatitis C, Chronic

Interventions

DRUG

buprenorphine

DRUG

methadone

DRUG

pegylated interferon alfa-2b plus ribavirin

Sponsors

Lead Sponsor

Collaborators (1)

AESCA Pharma GmbH

All Listed Sponsors

collaborator

AESCA Pharma GmbH

INDUSTRY

lead

Indivior Inc.

INDUSTRY

NCT00279565 - Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED) | Biotech Hunter | Biotech Hunter